PDCD1 and melanoma: Studies that investigated coinhibitory receptor expression by NY-ESO-1-specific CD8+ T cells from advanced melanoma patients have shown that coexpression of PD-1 with TIM-3, BTLA and TIGIT indicate T cell dysfunction and exhaustion (20, 63, 118).